Michael Kaseta sold $275K of Liquidia (LQDA)

Executed Jan 14 2025, disclosed Jan 14 2025, the same day.

Value, as filed

$275K

23,370 sh × $11.78

Executed

Jan 14 2025

the trade date, as filed

Disclosed

Jan 14 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

MK Michael Kaseta CFO and COO profile →

Michael Kaseta (CFO and COO) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $5.7M of LQDA (142,390 sh across 4 lots, as filed), executed Apr 14.

The name

LQDA Liquidia Corporation LQDA · Healthcare · 93 filings in 24 months ticker →

Healthcare · Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary dis…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Michael Kaseta in LQDA

LQDASALE Liquidia Corporation $1.5M
20,430 sh across 2 lots
Exec Jul 13
Filed Jul 14 · 8:08 PM ET LQDASALE Liquidia Corporation $5.7M
142,390 sh across 4 lots
Exec Apr 14
Filed Apr 16 · 5:30 PM ET LQDASALE Liquidia Corporation $1.7M
42,779 sh across 2 lots
Exec Apr 10
Filed Apr 14 · 5:30 PM ET LQDASALE Liquidia Corporation $5.4M
133,789 sh × $40.24
Exec Apr 9
Filed Apr 13 · 5:30 PM ET LQDASALE Liquidia Corporation $1.4M
36,932 sh × $37.43
Exec Jan 12
Filed Jan 13 · 5:30 PM ET LQDASALE Liquidia Corporation $272K
11,630 sh × $23.41
Exec Oct 13 2025
Filed Oct 15 2025 · 5:30 PM ET LQDASALE Liquidia Corporation $524K
20,000 sh × $26.18
Exec Aug 15 2025
Filed Aug 19 2025 · 5:30 PM ET LQDASALE Liquidia Corporation $600K
30,000 sh × $20.00
Exec Aug 5 2025
Filed Aug 7 2025 · 5:30 PM ET